This inventor holds 1 USPTO granted patent. Top assignee: Compugen Ltd. Corporation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Menashe Elazar: Innovator in CD40-Receptor Variants
Introduction
Menashe Elazar is a notable inventor based in Mevaseret Zion, Israel. He has made significant contributions to the field of biotechnology, particularly through his work on the CD40 receptor. His innovative approach has led to the development of novel variants that have potential implications in medical research and treatment.
Latest Patents
Menashe holds a patent for "Splice variants of CD40-receptor." This invention concerns six novel variants resulting from alternative splicing of the CD40 receptor. The patent highlights the importance of these variants in understanding immune responses and their potential therapeutic applications.
Career Highlights
Menashe is associated with Compugent Ltd., where he continues to explore advancements in biotechnology. His work has been instrumental in pushing the boundaries of current knowledge regarding receptor biology and its implications in health and disease.
Collaborations
Menashe has collaborated with notable colleagues, including Kinneret Savitzky and Rami Khosravi. These partnerships have fostered a dynamic research environment, enhancing the potential for innovative discoveries.
Conclusion
Menashe Elazar's contributions to the field of biotechnology, particularly through his patent on CD40 receptor variants, underscore his role as a significant inventor. His ongoing work at Compugent Ltd. continues to pave the way for future advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile